Fmoc-N-methyl-L-norvaline
- CAS No.252049-05-1
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High purity Fmoc-N-methyl-L-norvaline (CAS 252049-05-1) for advanced peptide synthesis. ≥98% assay, globally shipped with COA.
Request a Quote & Full COAProduct Technical Details
Product Overview
Fmoc-N-methyl-L-norvaline is a specialized non-proteinogenic amino acid derivative designed for advanced peptide chemistry and pharmaceutical development. As a protected building block, it incorporates an N-methyl group which significantly alters the conformational properties of the resulting peptide chain. This modification is critical for researchers aiming to enhance metabolic stability, improve membrane permeability, and reduce hydrogen bonding potential in bioactive peptides. Our manufacturing process ensures consistent quality suitable for rigorous drug discovery pipelines.
The incorporation of N-methylated amino acids is a strategic approach in modern medicinal chemistry to overcome limitations associated with natural peptides, such as rapid enzymatic degradation. By utilizing this specific norvaline derivative, chemists can introduce steric constraints that lock peptides into bioactive conformations. The Fmoc protecting group offers orthogonality, allowing for seamless integration into solid-phase peptide synthesis (SPPS) protocols without interfering with other functional groups.
Key Specifications
We adhere to strict quality control standards to guarantee the reliability of every batch. The following table outlines the critical physical and chemical parameters verified during our internal QC process.
| Parameter | Specification |
|---|---|
| CAS Number | 252049-05-1 |
| Molecular Formula | C21H23NO4 |
| Molecular Weight | 353.412 |
| Appearance | White powder |
| Assay (Purity) | ≥98.0% |
| Melting Point | 130.0 to 135.0 °C |
| Storage Condition | Store at RT, sealed |
Industrial Applications
This compound serves as a vital intermediate in the synthesis of complex therapeutic peptides and peptidomimetics. It is extensively used in the development of pharmaceutical agents where oral bioavailability is a key target. The N-methyl modification helps in reducing the polarity of the peptide backbone, facilitating better absorption across biological barriers. Additionally, it is employed in the creation of cyclic peptides and constrained structures used in diagnostic tools and research reagents.
Our clients in the biotechnology and pharmaceutical sectors utilize this building block for structure-activity relationship (SAR) studies. By systematically replacing natural amino acids with N-methylated variants like this norvaline derivative, researchers can optimize potency and selectivity. The high purity level ensures minimal side reactions during coupling steps, leading to higher overall yields in multi-step synthesis sequences.
Quality Assurance and Handling
Every production lot undergoes comprehensive analytical testing including HPLC, NMR, and mass spectrometry to confirm identity and purity. We provide a Certificate of Analysis (COA) with each shipment to document compliance with specified standards. Proper handling is essential to maintain product integrity. The material should be kept in a cool, dry, and well-ventilated area away from direct sunlight. Containers must remain tightly closed when not in use to prevent moisture absorption which could affect coupling efficiency.
We offer flexible packaging options to meet diverse laboratory and industrial needs, typically supplying in 25kg drums or customized units based on client requirements. Our global logistics network ensures timely delivery while maintaining cold chain or standard stability conditions as needed. For large-scale manufacturing projects, we support bulk pricing structures and can assist with technical documentation required for regulatory filings. Partner with us for reliable supply chain solutions in advanced peptide building blocks.
